Michael Schultz

11.4k total citations · 1 hit paper
108 papers, 4.9k citations indexed

About

Michael Schultz is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Michael Schultz has authored 108 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Genetics, 31 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Michael Schultz's work include Inflammatory Bowel Disease (30 papers), Microscopic Colitis (20 papers) and Gut microbiota and health (20 papers). Michael Schultz is often cited by papers focused on Inflammatory Bowel Disease (30 papers), Microscopic Colitis (20 papers) and Gut microbiota and health (20 papers). Michael Schultz collaborates with scholars based in New Zealand, United States and Germany. Michael Schultz's co-authors include R. Balfour Sartor, Levinus A. Dieleman, Susan L. Tonkonogy, Rance K. Sellon, D Rennick, Heiko C. Rath, Jürgen Schölmerich, Hans‐Jörg Linde, Jon A. Vanderhoof and Claudia Veltkamp and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Gastroenterology.

In The Last Decade

Michael Schultz

103 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice

1998 1.2k citations Susan L. Tonkonogy, Michael Schultz et al. profile →

Peers

Countries citing papers authored by Michael Schultz

Since Specialization

Citations

This map shows the geographic impact of Michael Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schultz more than expected).

Fields of papers citing papers by Michael Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schultz. The network helps show where Michael Schultz may publish in the future.

Co-authorship network of co-authors of Michael Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schultz. A scholar is included among the top collaborators of Michael Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schultz. Michael Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inflammatory Bowel Diseases and Nutrition 2024 ·Proceedings of The Nutrition Society ·Michael Schultz	1
2	Inflammatory Bowel Disease exercise and diet (IBDeat) habits study: exploring lifestyle habits and cardiometabolic disease risk factors 2024 ·Proceedings of The Nutrition Society ·(unknown), Catherine Wall, Robert G. Turner, Kim Meredith‐Jones, H. Osborne, Michael Schultz	1
3	Improving Medication Adherence Levels in Inflammatory Bowel Disease (IBD) Patients: A Narrative Evidence-Based Review 2024 ·Patient Preference and Adherence ·(unknown), (unknown), Rhiannon Braund, Michael Schultz	2
4	Current state of dietetic services for inflammatory bowel disease patients in New Zealand: an observational study 2023 ·Nutrition & Dietetics ·(unknown), Michael Schultz, Catherine Wall	6
5	“It's just like putting your socks on”: patients' perspectives on inflammatory bowel disease medication adherence 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rhiannon Braund, Michael Schultz	5
6	A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease 2022 ·Digestive Diseases and Sciences ·(unknown), Angharad Vernon‐Roberts, Christine Ho, Michael Schultz, Andrew S. Day	10
7	Successful use of generic direct acting antiviral medications to treat hepatitis C-a New Zealand-wide study. 2020 ·PubMed ·(unknown), (unknown), Steve Johnson, (unknown), Michael Schultz	0
8	ABC score: a new risk score that accurately predicts mortality in acute upper and lower gastrointestinal bleeding: an international multicentre study 2020 ·Gut ·Stig Borbjerg Laursen, Kathryn Oakland, Loren Laine, (unknown), Riccardo Marmo, Eduardo Redondo‐Cerezo, Harry R. Dalton, Jeffrey Ngu, Michael Schultz, Marco Soncini, Ian M. Gralnek, Vipul Jairath, Iain Murray, Adrian J. Stanley	88
9	Patients’ accounts of living with and managing inflammatory bowel disease in rural Southern New Zealand: a qualitative study 2020 ·BMJ Open ·Lauralie Richard, Geoff Noller, Sarah Derrett, Trudy Sullivan, Fiona Doolan‐Noble, Andrew McCombie, Michael Schultz, Christine Ho, Tim Stokes	7
10	Infliximab and adalimumab concentrations and anti‐drug antibodies in inflammatory bowel disease control using New Zealand assays 2018 ·Internal Medicine Journal ·Murray L. Barclay, (unknown), (unknown), (unknown), Barry D. Hock, Lisa K. Stamp, Michael Schultz	8
11	Detailed Multi-Dimensional Assessment of Fatigue in Inflammatory Bowel Disease 2018 ·Inflammatory Intestinal Diseases ·(unknown), (unknown), Hamish Osborne, Christine Ho, (unknown), (unknown), Catherine Hobbs, Michael Schultz	26
12	Awareness of coeliac disease among chefs and cooks depends on the level and place of training. 2017 ·PubMed ·Michael Schultz, Seong A. Shin, Kirsten J. Coppell	10
13	Use of pethidine for percutaneous liver biopsy – a randomised, placebo-controlled, double blind study 2015 ·BMC Gastroenterology ·(unknown), (unknown), (unknown), Martin Schlup, (unknown), (unknown), Sarah Buckingham, Michael Schultz	4
14	PTU-145 Incidence of Eosinophilic Oesophagitis in a New Zealand Population: A Retrospective Analysis 2013 ·Gut ·Iain Murray, (unknown), (unknown), (unknown), J Palmer, Michael Schultz	0
15	Is the north to south gradient in inflammatory bowel disease a global phenomenon? 2012 ·Expert Review of Gastroenterology & Hepatology ·Michael Schultz, Grant Butt	22
16	Unusual manifestation of Erdheim-Chester disease 2011 ·BMC Gastroenterology ·(unknown), (unknown), Martin Schlup, (unknown), Michael Schultz	29
17	Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo 2005 ·Journal of Microbiological Methods ·Michael Schultz, (unknown), Tobias A. Oelschlaeger, Heiko C. Rath, Claudia Göttl, Norbert Lehn, Jürgen Schölmerich, Hans‐Jörg Linde	45
18	Lactobacillus plantarum 299V in the Treatment and Prevention of Spontaneous Colitis in Interleukin-10-Deficient Mice 2002 ·Inflammatory Bowel Diseases ·Michael Schultz, Claudia Veltkamp, Levinus A. Dieleman, (unknown), (unknown), Susan L. Tonkonogy, R. Balfour Sartor	290
19	Oral administration of Lactobacillus GG (LGG) induces an antiinflammatory, TH-2 mediated systemic immune response towards intestinal organisms 2000 ·Gastroenterology ·Michael Schultz, (unknown), (unknown), Norbert Lehn, Werner Falk, Juergen Schöelmerich	11
20	Effects of antibiotics on the initiation and perpetuation of colitis in the IL-10 KO mice 1998 ·Gastroenterology ·Henri Braat, (unknown), (unknown), Michael Schultz, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact